*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
"Effectiveness Of Anticholinergic Agents In Antipsychotic Induced Rabbit Syndrome: A Meta-Analysis".

Author: AHALYA KRISHNAN, CHITRA C NAIR, PROF (DR) SHAIJU S DHARAN
Abstract: Background: The purpose of the current study is to analyse the management of Rabbit Syndrome(RS) in psychiatric patients who were treated with long term anti- psychotic drugs. Rabbit syndrome is a rare side effect of long term use of antipsychotics, and is characterised by the rapid and rhythmic movements of oral cavity in vertical manner, at a frequency of 4-6 Hz, usually 5 Hz. Method: An extensive search was performed in PubMed, CDSR, NHS Evidence, NIHR-HTA, WHO Global Index Medicus, and ClinicalTrials.gov until the end of September 22, 2020. The systematic review and meta analysis was performed in accordance with PRISMA guidelines and MOOSE checklist. English language articles between 1964 to September 2020 were screened manually and the related studies were finally included. Results: From extensive electronic database and literature search, and screening using PRISMA guidelines, 31 studies were included in the review. The studies were assessed for effectiveness of anticholinergics in managing rabbit syndrome. RS was found to develop more frequently in females than the male counterparts, and occurred mostly in middle aged and elderly individuals. Mood disorder and antipsychotic use are potential risk factors. On statistical analysis using Review Manager 5.4.1, it was found out that there is 20% less chance of RS symptom resolution in people taking anticholinergics to manage rabbit syndrome.
Keyword: Rabbit syndrome, antipsychotics, adverse events
DOI: https://doi.org/10.31838/ijpr/2021.13.02.434
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free